IL197760A - Use of cyclicals that form a complex with primary or secondary amine or guanidine groups which have been protonated to make preparations containing active substance bearing these groups - Google Patents
Use of cyclicals that form a complex with primary or secondary amine or guanidine groups which have been protonated to make preparations containing active substance bearing these groupsInfo
- Publication number
- IL197760A IL197760A IL197760A IL19776009A IL197760A IL 197760 A IL197760 A IL 197760A IL 197760 A IL197760 A IL 197760A IL 19776009 A IL19776009 A IL 19776009A IL 197760 A IL197760 A IL 197760A
- Authority
- IL
- Israel
- Prior art keywords
- groups
- protonated
- pharmaceutical
- complex
- manufacture
- Prior art date
Links
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical class NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 title 1
- 239000013543 active substance Substances 0.000 title 1
- 150000001923 cyclic compounds Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 125000002924 primary amino group Chemical class [H]N([H])* 0.000 title 1
- 125000000467 secondary amino group Chemical class [H]N([*:1])[*:2] 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polyesters Or Polycarbonates (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06020286A EP1905454A1 (en) | 2006-09-27 | 2006-09-27 | Formulations comprising cyclic compounds |
| PCT/EP2007/008442 WO2008037484A2 (en) | 2006-09-27 | 2007-09-27 | Formulations comprising cyclic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL197760A0 IL197760A0 (en) | 2009-12-24 |
| IL197760A true IL197760A (en) | 2016-10-31 |
Family
ID=37728182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL197760A IL197760A (en) | 2006-09-27 | 2009-03-23 | Use of cyclicals that form a complex with primary or secondary amine or guanidine groups which have been protonated to make preparations containing active substance bearing these groups |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8513188B2 (https=) |
| EP (2) | EP1905454A1 (https=) |
| JP (1) | JP5335677B2 (https=) |
| CN (2) | CN101557829A (https=) |
| AU (1) | AU2007302270B2 (https=) |
| BR (1) | BRPI0714761B8 (https=) |
| CA (1) | CA2664568C (https=) |
| ES (1) | ES2691736T3 (https=) |
| IL (1) | IL197760A (https=) |
| WO (1) | WO2008037484A2 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012012945A2 (pt) | 2009-11-25 | 2020-12-29 | Arisgen Sa | Composição de liberação mucosal, seu método de produção, complexo de peptídeo pré-formado, kit e uso de um agente ativo de peptídeo |
| EP2332929A1 (en) * | 2009-11-25 | 2011-06-15 | ArisGen SA | Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions |
| EP2526971A1 (en) | 2011-05-25 | 2012-11-28 | ArisGen SA | Mucosal delivery of drugs |
| CN102863358B (zh) * | 2012-09-20 | 2014-02-12 | 华中农业大学 | 具有除草活性的化合物及其制备方法 |
| EP3000811B1 (en) * | 2014-09-24 | 2017-11-08 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Crown Ether Complexes and Methods for Poducing the Same |
| US9744209B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| US9937223B2 (en) | 2015-01-30 | 2018-04-10 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| US9750785B2 (en) | 2015-01-30 | 2017-09-05 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| US9687526B2 (en) | 2015-01-30 | 2017-06-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| US9744239B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| US9925233B2 (en) | 2015-01-30 | 2018-03-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
| CN108658264B (zh) * | 2018-04-17 | 2021-05-25 | 唐山师范学院 | 多支化聚环氧琥珀酸衍生物阻垢缓蚀剂的制备及其应用方法 |
| CN113527672B (zh) * | 2020-03-30 | 2022-09-20 | 复旦大学 | 一种胍基衍生物及其基因递释系统 |
| CN116178887B (zh) * | 2023-02-16 | 2024-10-29 | 东华大学 | 一种可降解快递袋材料及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2923787A1 (de) * | 1979-06-12 | 1980-12-18 | Max Planck Gesellschaft | Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel |
| US4474753A (en) * | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Topical drug delivery system utilizing thermosetting gels |
| JP2583777B2 (ja) * | 1985-12-04 | 1997-02-19 | シエ−，デイ−ン | 医薬品の経皮施与 |
| US5023252A (en) * | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| ES2569916T3 (es) * | 1999-06-29 | 2016-05-13 | Mannkind Corporation | Formulaciones farmacéuticas que comprenden insulina complejada con una dicetopiperazina |
| EP1219616A4 (en) * | 1999-09-20 | 2002-11-06 | Amato Pharm Prod Ltd | PROCESS FOR THE PREPARATION OF CYCLIC LACTIC ACID OLIGOMERS |
| AU2002359679B2 (en) * | 2001-12-11 | 2009-01-08 | Cellgate, Inc. | Guanidinium transport reagents and conjugates |
| JP2006232909A (ja) * | 2005-02-23 | 2006-09-07 | Tokai Univ | 環状オリゴ乳酸 |
-
2006
- 2006-09-27 EP EP06020286A patent/EP1905454A1/en not_active Withdrawn
-
2007
- 2007-09-26 CN CNA2007800425762A patent/CN101557829A/zh active Pending
- 2007-09-27 ES ES07818525.3T patent/ES2691736T3/es active Active
- 2007-09-27 CN CN200780043437.1A patent/CN101541346B/zh not_active Expired - Fee Related
- 2007-09-27 BR BRPI0714761A patent/BRPI0714761B8/pt not_active IP Right Cessation
- 2007-09-27 WO PCT/EP2007/008442 patent/WO2008037484A2/en not_active Ceased
- 2007-09-27 US US12/443,327 patent/US8513188B2/en not_active Expired - Fee Related
- 2007-09-27 JP JP2009529613A patent/JP5335677B2/ja not_active Expired - Fee Related
- 2007-09-27 EP EP07818525.3A patent/EP2068934B8/en not_active Not-in-force
- 2007-09-27 AU AU2007302270A patent/AU2007302270B2/en not_active Ceased
- 2007-09-27 CA CA2664568A patent/CA2664568C/en active Active
-
2009
- 2009-03-23 IL IL197760A patent/IL197760A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2068934A2 (en) | 2009-06-17 |
| CN101557829A (zh) | 2009-10-14 |
| AU2007302270B2 (en) | 2014-05-29 |
| AU2007302270A1 (en) | 2008-04-03 |
| US8513188B2 (en) | 2013-08-20 |
| EP1905454A1 (en) | 2008-04-02 |
| BRPI0714761B8 (pt) | 2021-05-25 |
| JP5335677B2 (ja) | 2013-11-06 |
| CN101541346B (zh) | 2014-07-02 |
| WO2008037484A3 (en) | 2008-12-18 |
| JP2010504934A (ja) | 2010-02-18 |
| CA2664568C (en) | 2015-11-24 |
| EP2068934B8 (en) | 2018-09-05 |
| WO2008037484A2 (en) | 2008-04-03 |
| EP2068934B1 (en) | 2018-07-18 |
| ES2691736T3 (es) | 2018-11-28 |
| CA2664568A1 (en) | 2008-04-03 |
| BRPI0714761B1 (pt) | 2021-03-23 |
| BRPI0714761A2 (pt) | 2013-07-02 |
| US20100137188A1 (en) | 2010-06-03 |
| CN101541346A (zh) | 2009-09-23 |
| IL197760A0 (en) | 2009-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL197760A (en) | Use of cyclicals that form a complex with primary or secondary amine or guanidine groups which have been protonated to make preparations containing active substance bearing these groups | |
| IL250937A0 (en) | Pharmaceutical preparations and kits containing sphingomyelinase acid | |
| IL199362A (en) | Pyridopyrimidine Compounds, Pharmaceuticals, Compounds for Use as a Drug, and Compounds for Manufacture @ Drug | |
| IL193678A (en) | Derivatives of pyrazolyl-theophane, pharmaceuticals containing them and their use in the preparation of drugs to improve cognitive activity | |
| IL233677A (en) | Benzysacazole Compounds Aminopyrazolo-Primidine Converted, Pharmaceuticals Containing Them, and Use of Drug Manufacturing Composition | |
| IL198301A (en) | Aryl amides are stored in thiazole and oxazole, a pharmaceutical preparation containing them and their use in the preparation of drugs | |
| EP2220093A4 (en) | METHOD FOR THE PRODUCTION OF SITAGLIPTIN AND PHARMACEUTICAL ACCEPTABLE SALTS THEREOF | |
| PL2480539T3 (pl) | N-(1,2,5-oksadiazol-3-ilo)benzamidy i ich zastosowanie jako herbicydy | |
| IL202892A (en) | Diphthoid drugs, the process of making and using them to make the resulting drugs and drugs | |
| ZA200805939B (en) | Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
| IL228402A0 (en) | Nitro-cyclic compounds, their pharmaceutical preparations and their uses | |
| IL199835A (en) | Acid-activated antimicrobial peptides, their pharmaceutical preparations, and their use in drug preparation | |
| IL225198A (en) | Aminotetrahydropyrenic Compounds, Pharmaceutical Preparations Containing Them and Their Use in the Treatment of Diabetes | |
| IL193049A0 (en) | Pharmaceutical compositions comprising dextromethorphan and quinidine for the tretment of depression, anxiety, and neurodegenerative disordes | |
| IL189781A0 (en) | Sulphonylpyrrole hydrochloride salts and pharmaceutical compositions containing the same | |
| IL195360A (en) | Prodrug of phenolic opioids, a method of preparing them, a drug that includes them and their use | |
| IL209267A (en) | Combinations containing methotrexate and dhodh inhibitors and their use in the preparation of the drug | |
| PL2012765T3 (pl) | Płynne kompozycje zawierające fenylefrynę i acetaminofen oraz ich zastosowanie do leczenia chorób układu oddechowego | |
| EP2370401A4 (en) | AMIDE-LINKED PERFLUOROPOLYETHER THIOLS COMPOUNDS AND METHODS FOR PREPARING AND USING SAME | |
| IL203329A (en) | Compounds and their use in the manufacture of anti-fibrosis drugs | |
| IL210549A (en) | Pipedrine - Quinocosalin-Mediated Conjugated Drugs | |
| IL211018A (en) | Inhibitors, processes for making them, medicinal preparations containing them and their use | |
| IL203051A (en) | Use of alpha-ketoglutarate for drug preparation | |
| IL218644A (en) | Pharmaceuticals containing the active substances metformin and cytagliptin or vilagagliptin | |
| BRPI1009392A2 (pt) | "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica." |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| MM9K | Patent not in force due to non-payment of renewal fees |